YD Bio Ltd

BRZH

Not Compliant
Exchange
Sector
Headquarters
Group
OTC
Healthcare
Taiwan
Small cap

YD Bio Ltd is not Shariah Compliant because it fails the financial ratios.

8.16%

Impure Income*

-

Purification*

-

Zakat*

Financials

Market cap Group
Analysts' Rating
Price Target (Mean)
Price Target (Low)
Price Target (High)
Total Analysts
Small cap
0
$0
$0.00
$0.00
0
Revenue Growth
Operating Margin
Net Profit Margin
Quick Ratio
Current Ratio
EPS Growth
Unable to collect data for the field 'TR.F.TotRevYoYPctChg' and some specific identifier(s).%
Unable to collect data for the field 'TR.F.OpMargPct' and some specific identifier(s).%
0.00%
Unable to collect data for the field 'TR.F.QuickRatio' and some specific identifier(s).
Unable to collect data for the field 'TR.F.CurrRatio' and some specific identifier(s).
0.00%

Shariah Compliance

  • Updated on September 24, 2025
Debt
✓
Non-Compliant Assets
✓
Impure Income
8.16%
✗

AAOIFI Rulebook:

  • Non-compliant Liabilities (like Interest-based Debt) < 30% of Market cap
  • Non-compliant Assets (like Interest-based Investments) < 30% of Market cap
  • Impure Revenues (incl. Interest Income) < 5% of Total Revenues

Source: AAOIFI SS21

Debt
✓
Impure Income
8.16%
✗

S&P Sharia Rulebook:

  • Interest-based Debt < 33% of 36-mo avg. Market cap
  • Impure Revenues (incl. Interest Income) < 5% of Total Revenues

Source: S&P Shariah Methodology

Debt
✓
Impure Income
8.16%
✗

Dow Jones Islamic Market (DJIM) Rulebook:

  • Interest-based Debt < 33% of 24-mo avg. Market cap
  • Impure Revenues (incl. Interest Income) < 5% of Total Revenues

Source: DJIM Methodology

Debt
✓
Cash
0.21%
✓
Cash & AR
0.21%
✓
Impure Income
8.16%
✗

FTSE Shariah Rulebook:

  • Interest-based Debt < 33.33% of Total Assets
  • Cash and interest-bearing items < 33.33% of Total Assets
  • Accounts receivable and cash < 50% of Total Assets
  • Impure Revenues (incl. Interest Income) < 5% of Total Revenues

Source: FTSE RUSSELL

Debt
✓
Cash
0.21%
✓
Cash & AR
0.21%
✓
Impure Income
8.16%
✗

MSCI Islamic Rulebook:

  • Interest-based Debt < 33.33% of Total Assets
  • Cash and interest-bearing items < 33.33% of Total Assets
  • Accounts receivable and cash < 33.33% of Total Assets
  • Impure Revenues (incl. Interest Income) < 5% of Total Revenues

Source: MSCI Islamic Indexes

Impure Income Breakdown

-
-
Interest Income
8.16%

Note on Purification and Zakat:

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

YD Bio Ltd is a Taiwan-based company principally engaged in pioneering transformative solutions from early cancer detection to next-generation cell therapies to improve and extend patient lives. The Company’s core areas include non-invasive cancer detection tools for early diagnosis and monitoring, ophthalmologic products targeting dry eye conditions, and exosome-based therapeutics aimed at treating complex diseases. By integrating cutting-edge science with accessible solutions, YD Bio strives to improve patient outcomes and quality of life.

Found the Stock You’re Looking For? Open an Account Today!

Opening an account has never been easier! Please fill out the form here and an advisor will be in touch to walk you through the process!

Still have some further questions?

Schedule a Free Consultation